Recombinant human CD40 protein (Fc Chimera Active) is a Human Fragment protein, in the 21 to 193 aa range, expressed in CHO, with >=98% purity, < 0.06 EU/µg endotoxin level and suitable for SDS-PAGE, FuncS.
E P P T A C R E K Q Y L I N S Q C C S L C Q P G Q K L V S D C T E F T E T E C L P C G E S E F L D T W N R E T H C H Q H K Y C D P N L G L R V Q Q K G T S E T D T I C T C E E G W H C T S E A C E S C V L H R S C S P G F G V K Q I A T G V S D T I C E P C P V G F F S N V S S A F E K C H P W T S C E T K D L V V Q Q A G T N K T D V V C G P Q D R L R
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application FuncS | Reactivity Reacts | Dilution info - | Notes - |
Select an associated product type
Receptor for TNFSF5/CD40LG (PubMed:31331973). Transduces TRAF6- and MAP3K8-mediated signals that activate ERK in macrophages and B cells, leading to induction of immunoglobulin secretion (By similarity).
CD40, TNFRSF5, Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, Bp50, CD40L receptor, CDw40
Recombinant human CD40 protein (Fc Chimera Active) is a Human Fragment protein, in the 21 to 193 aa range, expressed in CHO, with >=98% purity, < 0.06 EU/µg endotoxin level and suitable for SDS-PAGE, FuncS.
Constituents: 100% PBS
Receptor for TNFSF5/CD40LG (PubMed:31331973). Transduces TRAF6- and MAP3K8-mediated signals that activate ERK in macrophages and B cells, leading to induction of immunoglobulin secretion (By similarity).
This product is an active protein and may elicit a biological response in vivo, handle with caution.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com